Disclosure of Certain Broncus Future IP. Subject to the confidentiality provisions of Section 11 of this Agreement, Broncus will disclose in confidence to Asthmatx any Broncus Future IP that is described in Section 1.7(b)(ii) above that may be developed by Broncus. Such disclosure will be made within a reasonable time after such Broncus Future IP has been developed and reduced to practice.
Appears in 5 contracts
Samples: Cross License Agreement (Asthmatx Inc), Cross License Agreement (Asthmatx Inc), Cross License Agreement (Broncus Technologies Inc/Ca)